rs2270894

This variant is located in the CRELD1 gene.

GWAS Catalog Trait Associations (12)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

cysteine-rich with EGF-like domain protein 1 measurement

Pietzner M et al. Mapping the proteo-genomic convergence of human diseases. Science (new York, N.y.) 374(6569):eabj1541 (2021)
Allele C
OR 0.86
p
N 10,708
Large GWAS
European
Sun BB et al. Genomic atlas of the human plasma proteome. Nature 558(7708):73-79 (2018)
Allele C
OR 0.84
p 2.0e-186
N 3,301
Large GWAS
European

blood protein amount

Allele G
OR 0.71
p 4.0e-267
N 5,364
Large GWAS
European

appendicular lean mass

Allele C
OR 0.03
p 1.0e-42
N 450,243
Major Consortium StudyLarge GWAS
European

level of membrane primary amine oxidase in blood

Allele G
OR 0.06
p 3.0e-27
N 47,745
Large GWAS
European

whole body water mass

Allele G
OR 0.01
p 1.0e-23
N 394,642
Large GWAS
European

base metabolic rate measurement

Allele G
OR 0.01
p 8.0e-22
N 394,642
Large GWAS
European

health trait

Allele C
OR 0.01
p 1.0e-20
N 405,979
Large GWAS
European

lean body mass

Harris BHL et al. New role of fat-free mass in cancer risk linked with genetic predisposition. Scientific Reports 14(1):7270 (2024)
Allele G
OR 0.02
p 5.0e-19
N 337,739
Large GWAS
European

hip circumference

Allele G
OR 0.02
p 2.0e-14
N 394,642
Large GWAS
European

ClinVar annotation

Benign★★★
2 submitters1 publication
View on ClinVar →

About CRELD1

This gene encodes a member of a subfamily of epidermal growth factor-related proteins. The encoded protein is characterized by a cysteine-rich with epidermal growth factor-like domain. This protein may function as a cell adhesion molecule. Mutations in this gene are the cause of atrioventricular septal defect. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Apr 2010]

View all CRELD1 variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…